XBiotech (XBIT) Stock: Buy, Sell, or Hold?
XBIT - XBiotech Inc
$2.15
-0.02 (-0.92%)
▼
5d:
-1.38%
30d:
-6.52%
90d:
-7.73%
WAIT
LOW Confidence
Analysis Updated: Sep 28, 2026 12:00 AM ET
Earnings: Nov 11, 2026
Get Alerted When XBIT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: XBIT shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: XBIT shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: XBIT is currently trading at $2.15, which is considered oversold relative to its 30-day fair value range of $2.16 to $2.27.
Technical Outlook: Technically, XBIT is in a strong downtrend. The price is currently testing key support at $2.14. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: XBIT scores 65/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $18.00 (+737.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, XBIT is in a strong downtrend. The price is currently testing key support at $2.14. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: XBIT scores 65/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $18.00 (+737.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$2.16 -
$2.27
Company Quality Score
50/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
94.7%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (65/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 737.2% below Wall St target ($18.00)
- WARNING: Composite score 50/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$2.16 -
$2.27
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$2.14
Resistance Level
$2.22
Current Trend
Strong Downtrend
Technical data as of
Sep 28, 2026
Fundamental Context
Wall Street Target
$18.00
(+737.2%)
Revenue Growth (YoY)
-93.3%
Share & Embed Analysis
Last updated: September 29, 2026 7:45 AM ET
Data refreshes hourly during market hours. Next update: 8:45 AM
Data refreshes hourly during market hours. Next update: 8:45 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is XBIT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1180 | 67 BUY |
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$47 | 59 HOLD |
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$22 | 43 HOLD |
|
BNTX
BioNTech SE |
STRONG BUY
21 analysts |
$118 | 65 BUY |
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
20 analysts |
$139 | 61 BUY |
